The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
How I treat patients with massive hemorrhage
Abstract
Massive hemorrhage is associated with coagulopathy and high mortality. The transfusion guidelines up to 2006 recommended that resuscitation of massive hemorrhage should occur in successive steps using crystalloids, colloids, and red blood cells (RBCs) in the early phase and plasma and platelets in the late phase. With the introduction of the cell-based model of hemostasis in the mid-1990s, our understanding of the hemostatic process and of coagulopathy has improved. This has contributed to a change in resuscitation strategy and transfusion therapy of massive hemorrhage along with an acceptance of the adequacy of whole blood hemostatic tests to monitor these patients. Thus, in 2005, a strategy aiming at avoiding coagulopathy by proactive resuscitation with blood products in a balanced ratio of RBC:plasma:platelets was introduced, and this has been reported to be associated with reduced mortality in observational studies. Concurrently, whole blood viscoelastic hemostatic assays have gained acceptance by allowing a rapid and timely identification of coagulopathy along with enabling an individualized, goal-directed transfusion therapy. These strategies joined together seem beneficial for patient outcome, although final evidence on outcome from randomized controlled trials are lacking. We present how we in Copenhagen and Houston, today, manage patients with massive hemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weber, C. F., Görlinger, K., Meininger, D., Herrmann, E., Bingold, T., Moritz, A., Cohn, L. H., & Zacharowski, K. (2012) · Anesthesiology · doi:10.1097/aln.0b013e318264c644 · Cited by 625
The Relationship of Blood Product Ratio to Mortality: Survival Benefit or Survival Bias?
Snyder, C. W., Weinberg, J. A., McGwin, G., Melton, S. M., George, R. L., Reiff, D. A., Cross, J. M., Hubbard-Brown, J., Rue, L. W., & Kerby, J. D. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e318196c3ac · Cited by 384
Optimizing the use of blood products in trauma care.
(2005) · Critical Care · doi:10.1186/cc3780 · Cited by 63
Cited by
Holcomb, J. B., Tilley, B. C., Baraniuk, S., Fox, E. E., Wade, C. E., Podbielski, J. M., del Junco, D. J., Brasel, K. J., Bulger, E. M., Callcut, R. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.12 · Cited by 2,526
Self-citationRossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Spahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
Wikkelsø, A., Wetterslev, J., Møller, A. M., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007871.pub3 · Cited by 400
Johansson, P., Stensballe, J., & Ostrowski, S. (2017) · Critical Care · doi:10.1186/s13054-017-1605-5 · Cited by 360
Self-citation
Metadata
- Authors
- Johansson, P. I., Stensballe, J., Oliveri, R., Wade, C. E., Ostrowski, S. R., & Holcomb, J. B.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2014-11-13
- Volume
- 124
- Issue
- 20
- Pages
- 3052-3058
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2092158875
- Cited by
- 196
- References
- 3
- FWCI
- 21.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How I treat patients with massive hemorrhage. https://app.cochat.ai/papers/10.1182/blood-2014-05-575340
- The paper
- Johansson, P. I., Stensballe, J., Oliveri, R., Wade, C. E., Ostrowski, S. R., & Holcomb, J. B. (2014). How I treat patients with massive hemorrhage. Blood. https://doi.org/10.1182/blood-2014-05-575340
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.